Načítá se...
Three years of treatment with minodronate in patients with postmenopausal osteoporosis
The objective of this study was to determine the safety and efficacy of long-term minodronate treatment in women with postmenopausal osteoporosis based on re-analysis of a phase III 2-year clinical trial with a 1-year extension. Women aged 55–80 years old with fragility fractures were enrolled and r...
Uloženo v:
Hlavní autoři: | , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Springer Japan
2011
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3396350/ https://ncbi.nlm.nih.gov/pubmed/22134624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00774-011-0332-2 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|